APP/Amyloid beta Human Monoclonal Antibody
Anti-Human APP/Amyloid beta (BCDXCE64) is a research-grade recombinant antibody targeting AICD-57. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF (50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID (59), Amyloid intracellular domain 59, AID (57), S-APP-alpha, Gamma-CTF (59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID (50), Alpha-CTF, Gamma-CTF (57), AICD-50
UniProt
P05067
Reactivity
Human
Clonality
Monoclonal
Clone
BCDXCE64
Conjugation
Unconjugated
Field of Research
Neuroscience; Cell Biology
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY428499 100 µg
LI Cadherin (CDH17) (NM_001144663) Human Over-expression Lysate
Sign In for Pricing
View Details 
